Cargando…
Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
BACKGROUND: Soy isoflavones show structural and functional similarities to estradiol. Available data indicate that estradiol and estradiol-like components may interact with gut "satiety hormones" such as peptide YY (PYY) and ghrelin, and thus influence body weight. In a randomized, double-...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1562443/ https://www.ncbi.nlm.nih.gov/pubmed/16907966 http://dx.doi.org/10.1186/1477-5751-5-11 |
_version_ | 1782129504010895360 |
---|---|
author | Weickert, Martin O Reimann, Manja Otto, Bärbel Hall, Wendy L Vafeiadou, Katherina Hallund, Jesper Ferrari, Marika Talbot, Duncan Branca, Francesco Bügel, Susanne Williams, Christine M Zunft, Hans-Joachim Koebnick, Corinna |
author_facet | Weickert, Martin O Reimann, Manja Otto, Bärbel Hall, Wendy L Vafeiadou, Katherina Hallund, Jesper Ferrari, Marika Talbot, Duncan Branca, Francesco Bügel, Susanne Williams, Christine M Zunft, Hans-Joachim Koebnick, Corinna |
author_sort | Weickert, Martin O |
collection | PubMed |
description | BACKGROUND: Soy isoflavones show structural and functional similarities to estradiol. Available data indicate that estradiol and estradiol-like components may interact with gut "satiety hormones" such as peptide YY (PYY) and ghrelin, and thus influence body weight. In a randomized, double-blind, placebo-controlled, cross-over trial with 34 healthy postmenopausal women (59 ± 6 years, BMI: 24.7 ± 2.8 kg/m(2)), isoflavone-enriched cereal bars (50 mg isoflavones/day; genistein to daidzein ratio 2:1) or non-isoflavone-enriched control bars were consumed for 8 weeks (wash-out period: 8-weeks). Seventeen of the subjects were classified as equol producers. Plasma concentrations of ghrelin and PYY, as well as energy intake and body weight were measured at baseline and after four and eight weeks of each intervention arm. RESULTS: Body weight increased in both treatment periods (isoflavone: 0.40 ± 0.94 kg, P < 0.001; placebo: 0.66 ± 0.87 kg, P = 0.018), with no significant difference between treatments. No significant differences in energy intake were observed (P = 0.634). PYY significantly increased during isoflavone treatment (51 ± 2 pmol/L vs. 55 ± 2 pmol/L), but not during placebo (52 ± 3 pmol/L vs. 50 ± 2 pmol/L), (P = 0.010 for treatment differences, independent of equol production). Baseline plasma ghrelin was significantly lower in equol producers (110 ± 16 pmol/L) than in equol non-producers (162 ± 17 pmol/L; P = 0.025). CONCLUSION: Soy isoflavone supplementation for eight weeks did not significantly reduce energy intake or body weight, even though plasma PYY increased during isoflavone treatment. Ghrelin remained unaffected by isoflavone treatment. A larger and more rigorous appetite experiment might detect smaller differences in energy intake after isoflavone consumption. However, the results of the present study do not indicate that increased PYY has a major role in the regulation of body weight, at least in healthy postmenopausal women. |
format | Text |
id | pubmed-1562443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-15624432006-09-08 Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women Weickert, Martin O Reimann, Manja Otto, Bärbel Hall, Wendy L Vafeiadou, Katherina Hallund, Jesper Ferrari, Marika Talbot, Duncan Branca, Francesco Bügel, Susanne Williams, Christine M Zunft, Hans-Joachim Koebnick, Corinna J Negat Results Biomed Research BACKGROUND: Soy isoflavones show structural and functional similarities to estradiol. Available data indicate that estradiol and estradiol-like components may interact with gut "satiety hormones" such as peptide YY (PYY) and ghrelin, and thus influence body weight. In a randomized, double-blind, placebo-controlled, cross-over trial with 34 healthy postmenopausal women (59 ± 6 years, BMI: 24.7 ± 2.8 kg/m(2)), isoflavone-enriched cereal bars (50 mg isoflavones/day; genistein to daidzein ratio 2:1) or non-isoflavone-enriched control bars were consumed for 8 weeks (wash-out period: 8-weeks). Seventeen of the subjects were classified as equol producers. Plasma concentrations of ghrelin and PYY, as well as energy intake and body weight were measured at baseline and after four and eight weeks of each intervention arm. RESULTS: Body weight increased in both treatment periods (isoflavone: 0.40 ± 0.94 kg, P < 0.001; placebo: 0.66 ± 0.87 kg, P = 0.018), with no significant difference between treatments. No significant differences in energy intake were observed (P = 0.634). PYY significantly increased during isoflavone treatment (51 ± 2 pmol/L vs. 55 ± 2 pmol/L), but not during placebo (52 ± 3 pmol/L vs. 50 ± 2 pmol/L), (P = 0.010 for treatment differences, independent of equol production). Baseline plasma ghrelin was significantly lower in equol producers (110 ± 16 pmol/L) than in equol non-producers (162 ± 17 pmol/L; P = 0.025). CONCLUSION: Soy isoflavone supplementation for eight weeks did not significantly reduce energy intake or body weight, even though plasma PYY increased during isoflavone treatment. Ghrelin remained unaffected by isoflavone treatment. A larger and more rigorous appetite experiment might detect smaller differences in energy intake after isoflavone consumption. However, the results of the present study do not indicate that increased PYY has a major role in the regulation of body weight, at least in healthy postmenopausal women. BioMed Central 2006-08-14 /pmc/articles/PMC1562443/ /pubmed/16907966 http://dx.doi.org/10.1186/1477-5751-5-11 Text en Copyright © 2006 Weickert et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Weickert, Martin O Reimann, Manja Otto, Bärbel Hall, Wendy L Vafeiadou, Katherina Hallund, Jesper Ferrari, Marika Talbot, Duncan Branca, Francesco Bügel, Susanne Williams, Christine M Zunft, Hans-Joachim Koebnick, Corinna Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women |
title | Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women |
title_full | Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women |
title_fullStr | Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women |
title_full_unstemmed | Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women |
title_short | Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women |
title_sort | soy isoflavones increase preprandial peptide yy (pyy), but have no effect on ghrelin and body weight in healthy postmenopausal women |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1562443/ https://www.ncbi.nlm.nih.gov/pubmed/16907966 http://dx.doi.org/10.1186/1477-5751-5-11 |
work_keys_str_mv | AT weickertmartino soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT reimannmanja soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT ottobarbel soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT hallwendyl soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT vafeiadoukatherina soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT hallundjesper soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT ferrarimarika soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT talbotduncan soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT brancafrancesco soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT bugelsusanne soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT williamschristinem soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT zunfthansjoachim soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen AT koebnickcorinna soyisoflavonesincreasepreprandialpeptideyypyybuthavenoeffectonghrelinandbodyweightinhealthypostmenopausalwomen |